Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
Victoria FurerDevy ZismanAdi KibariDoron RimarYael ParanOri ElkayamPublished in: Rheumatology (Oxford, England) (2021)
Epidemiologic studies on the safety of the mRNA-based COVID-19 vaccines in patients with AIIRD are needed to clarify the association between the BNT162b2 mRNA vaccination and reactivation of zoster.